Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
NKTR•Inducement grants report
- Nektar Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4).
Related News
First Business Financial Services CHRO Jodi A. Chandler sells 675 common shares for $47,381.29
FBIZ•
Eton Pharma director Paul V. Maier reports disposal of common shares worth $2.94 million
ETON•
Sunpower Enters Safe Agreement For $2 Million Investment On August 24, 2026 - SEC Filing
SPWR•
Obsidian Therapeutics Files Prospectus Relates To Resale Of Up To 29,164,045 Shares Of Common Stock By Selling Stockholders- SEC Filing
OBX•
Brief-Spero Therapeutics May Offer Up To $300 Million In Securities - SEC Filing
SPRO•